Clinical Trials Browser

Phase 3 × NIH × Uveal Melanoma × Clear all

NCT01989572 2020-07-07

Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery

Phase 3 Completed

815 enrolled 10 charts

Uveal Melanoma, Melanoma

NCT00000124 2006-06-02

Collaborative Ocular Melanoma Study (COMS)

Phase 3 Unknown

Uveal Melanoma, Choroid Neoplasms, Uveitis